Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.1%

17 terminated/withdrawn out of 542 trials

Success Rate

95.8%

+9.2% vs industry average

Late-Stage Pipeline

30%

162 trials in Phase 3/4

Results Transparency

12%

46 of 383 completed trials have results

Key Signals

24 recruiting46 with results14 terminated

Enrollment Performance

Analytics

N/A

228(49.7%)

Phase 3

108(23.5%)

Phase 2

57(12.4%)

Phase 4

54(11.8%)

Phase 1

12(2.6%)

459Total

N/A(228)

Phase 3(108)

Phase 2(57)

Phase 4(54)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (542)

Showing 20 of 542 trials

NCT06702423Not ApplicableCompleted

AI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan

Role: collaborator

NCT04330599Recruiting

Longitudinal Population-based Observational Study of COVID-19 in the UK Population

Role: collaborator

NCT06347471Phase 4Completed

The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy

Role: collaborator

NCT05890222Not ApplicableCompleted

IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion

Role: collaborator

NCT06983483Not ApplicableRecruiting

Structural Heat Adaptation and Education in Rural Setting

Role: collaborator

NCT06865495Not ApplicableCompleted

Evaluating the Individual and Combined Effects of Hand Hygiene Promotion and Hardware Provision on Handwashing With Soap in Lusaka, Zambia

Role: lead

NCT07657143Phase 4Not Yet Recruiting

Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma

Role: lead

NCT06007105Not ApplicableCompleted

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Role: lead

NCT05342064Not ApplicableActive Not Recruiting

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

Role: collaborator

NCT07592260Not ApplicableRecruiting

OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol.

Role: collaborator

NCT07591064Not ApplicableNot Yet Recruiting

Effectiveness of Positive Deviance/Hearth in Treating Uncomplicated Moderate Acute Malnutrition in Children 6-59 Months in Mymensingh Division, Bangladesh

Role: collaborator

NCT06347627Not ApplicableCompleted

Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18

Role: collaborator

NCT03700034Not ApplicableActive Not Recruiting

mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal

Role: collaborator

NCT06921213Phase 2Recruiting

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Role: lead

NCT02944682Not ApplicableCompleted

Household Air Pollution and Health: A Multi-country LPG Intervention Trial